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a dose of 500  mg/day, and after 4  months the patient was free
of symptoms.The S. apiospermum isolate was resistant to either
drug alone but susceptible in vitro to the combination [14]. It
was hypothesized that after changing the therapy to terbina-
¢ne, su¤cient levels of itraconazole would be present in the
lungs to allow synergistic interaction with terbina¢ne. In the
second case, a 2-year-old boy developed periorbital cellulitis
due to Pythium insidiosum. A high dose of amphotericin B was
clinically ine¡ective, and combination treatment with itraco-
nazole and terbina¢newas initiated based on the in vitro inter-
action of itraconazole with terbina¢ne against this isolate.The
child responded to this regimen [10].
Although de¢nitive data are lacking with respect to the
clinical e¤cacy of combination therapy for the treatment of
invasive scedosporiosis, the evidence that we have presented
suggests that the combination of an azole with terbina¢ne
should be considered for the treatment of invasive infections
by S. proli¢cans.
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Cerebral infarct and adult respiratory distress syndrome in
a patient with postanginal sepsis
Fusobacterium necrophorum is a virulent anaerobe, most com-
monly associated with pharyngotonsillitis in young adults
and children. Local complications include peritonsillar
abscesses, neck space infections and jugular vein septic throm-
bophlebitis. There may also be metastatic abscesses (most fre-
quently in the lungs, pleural space, liver and large joints)
related to bacteremia (postanginal sepsis or Lemierre syn-
drome) [1^5]. Rarely, retrograde spread of infection causes
cerebral abscess or meningitis. The ¢rst case of adult respira-
tory distress syndrome (ARDS) as a complication of postangi-
nal sepsis was described by Cosgrove et al in 1993 [6]. We
describe an adult patient with postanginal sepsis complicated
byARDS and cerebral infarct, to our knowledge the ¢rst case
in the literature.
The patient had been a healthy 20-year-old female with
no signi¢cant medical history. Seven days prior to admission,
acute pharyngitis was diagnosed and treated with oral ery-
thromycin. A throat culture was negative for b-hemolytic
streptococci.Three days later, she developed bilateral posterior
neck discomfort and sti¡ness and continued having low-grade
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fever. Because of gastrointestinal discomfort, erythromycin
was discontinued. Her neck symptoms improved slightly, but
on the morning of admission she awoke with shortness of
breath, dry cough and di¤culty in speaking and swallowing.
On admission, her temperature was 38.0  C, blood pressure
was150/60  mmHg, pulse rate was130/min and respiratory rate
was 21/min. The posterior pharynx was mildly erythematous
without exudate. No tenderness, swelling or induration at the
angle of the jaw or along the sternocleidomastoid muscles was
present; however, small, tender posterior lymph nodes were
palpable. There were rales in the lung bases bilaterally. No
heart murmur was audible.No rash, cutaneous signs of emboli
or neurologic de¢cits were noted.
Arterial blood gases, while the patient was breathing room
air, showed that the partial pressure of oxygen (PaO2) was 55  
mmHg, the partial pressure of carbon dioxide (PCO2) was 35  
mmHg and the pH was 7.46. A complete blood count yielded
the following values: white blood cell count 23  400/mm3
with 91% neutrophils; hemoglobin 11.2  g/dL; platelet count
125  000/mm3. The erythrocyte sedimentation rate was 100  
mm/h and there were no other laboratory abnormalities. A
chest roentgenogram showed extensive bilateral lower-lobe
in¢ltrates. Computed tomography (CT) of the neck with
contrast disclosed left paravertebral soft tissue prominence on
the sagittal scout view and multiple bilateral posterior triangle
lymph nodes with no pathologic enlargement. There was no
evidence of abscess. Blood cultures were drawn, and the
patient was treated with ceftriaxone (2 g once-daily IV) and
erythromycin (1 g every 6  h IV). Hypoxic respiratory failure
developed rapidly, requiring mechanical ventilation and 10
cmH2O positive end-expiratory pressure (PEEP).
On hospital day 3, blood cultures grew anaerobic Gram-
negative rods, later identi¢ed as F. necrophorum (with no b-lac-
tamase activity). Clindamycin was added to the medications.
A repeat CT of the neck showed a progressive in£ammatory
process in the left peripharyngeal region without £uid collec-
tion.The jugular veins and the left carotid artery were patent.
A radiograph and a CTof the chest were remarkable for exten-
sive alveolar in¢ltrates in both lungs and a small right pleural
e¡usion. The patient's hypoxemia worsened, and pressure-
controlled inverse ratio ventilation (PC-IRV) was initiated
with a mean airway pressure of 24 cmH20. Pulmonary capil-
lary wedge pressure was 20  mmHg, central venous pressure
was 18  mmHg, pulmonary artery pressure was 52/33  mmHg,
cardiac output was 9.1  L/min, and the cardiac index was 4.9  L/
min per m2 of body surface area. The systemic vascular resis-
tance was 422 dyn.s.cmÿ5. On hospital day 4, the patient
developed ¢xed and dilated pupils. CTof the head showed a
large infarct in the distribution of the left anterior and middle
cerebral arteries and left transtentorial herniation. The family
decided towithdraw support, and the patient died.
The major ¢ndings of the postmortem examination were
noted in the lungs and brain. The right and left lungs were
found to be heavy,weighing1670 and1450  g, respectively, con-
solidated and studded with multiple necrotic nodules. Micro-
scopic examination demonstrated extensive, well-developed
changes of ARDS, lobar pneumonia and abscesses. The brain
weighed 1430  g. The cerebral hemispheres were symmetrical.
Bilateral tonsilar herniation was noted. Sections showed no
gross focal lesions in the cerebrum, cerebellum or brain stem,
including the ventricular system and the vascular components.
Microscopic examination demonstrated di¡use bilateral cere-
bral edema. Liver and spleen showed ¢ndings consistent with
acute passive congestion, weighing 3750 and 430  g, respec-
tively. The neck was examined grossly by a dissection that
extended as high as possible, while simultaneously trying to
avoid dis¢gurement of the body. No macroscopic abnormal-
ities in the soft tissues or major arteries and veins of the neck
were noted,butmicroscopic evaluationwas notperformed.
Frequently, the history of a sore throat is overlooked in
patients with sepsis. It is not until anaerobic bacteria are iso-
lated from the blood or until multiple cavitary lesions appear
on X-rays of the chest that the diagnosis of postanginal sepsis
is considered. Signs of systemic toxicity usually appear 3^14  
days after a `benign'-appearing oropharyngeal infection. The
infection spreads to the peripharyngeal space through direct
extension, lymphatic spread or the pharyngeal venous chan-
nels. A serious complication can occur, suppurative jugular
thrombophlebitis, resulting in bacteremia and multiple septic
emboli, mostly to the lungs. Con¢rmation of the diagnosis of
suppurative thrombophlebitis can be obtained by ultrasonic
evaluation, contrast-enhanced CT scan of the neck and/or
radionuclide scans with gallium. Infection adjacent to the car-
otid artery may result in aneurysm formationwith subsequent
rupture and fatal bleeding. Compression of nearby structures
may produce Horner's syndrome or palsies of the ninth to
twelfth cranial nerves. Abnormal laboratory ¢ndings may
include marked leukocytosis, thrombocytosis, elevation of
liver functionvalues andmild jaundice.
Although a number of pleuropulmonary complications
have been associated with postanginal sepsis, including meta-
static lung abscesses and empyema, we found only a single case
report of presumed ARDS in the recent literature [6, 9^10]. In
our case, abrupt hypoxic respiratory failure was associated
with rapidly progressive bilateral alveolar in¢ltrates. Although
the measured pulmonary capillary wedge pressure was not R
18  mmHg, thus failing to ful¢ll strict criteria for ARDS, this
was in the setting of an elevated mean airway pressure, which
could have increased the measured value. Con¢rmation of this
clinical impression of ARDS was obtained from the micro-
scopic ¢ndings at autopsy.
Cerebral infarct occurring as a complication of postanginal
sepsis has not, to our knowledge, been reported in adults. In
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1989, Spenser et al described a case of a 23-month-old infant
inwhom F. necrophorum sepsis progressed to cerebral infarction
despite intravenous chloramphenicol and ampicillin therapy
[11]. The child ¢nally survived but had severe neurologic
sequelae. Although no de¢nite changes of cerebral infarction
were noted in the postmortem examination in our case, the
brief interval between the ischemic event and the time of
death possibly precluded the development of such diagnostic
microscopic ¢ndings, as seen on the CT scan [12, 13]. Infarcts
in young adults without atherosclerosis can occur as a result of
cerebral vasospasm, severe hypotension, coagulopathy, embo-
lism, hyperviscosity and vasculitis, although a focal arterial
occlusion is often not found post mortem [14, 15]. These fac-
tors alone or in combination are likely etiologies for the devel-
opment of cerebral infarct in this case.
In most cases, F. necrophorum is isolated from the blood of
patients with postanginal sepsis. F. necrophorum is an anaerobic,
non-spore-forming, Gram-negative rod, inhabiting the
mouth, alimentary tract and female genital tract [16]. Because
identi¢cation of the organism and susceptibility data are often
delayed, empirical therapy needs to be initiated with agents
that are clinically active against virtually all anaerobes, such as
b-lactams in combination with b-lactamase inhibitors (e.g.
clavulanate, sulbactam), imipenem (or newer carbapenems),
clindamycin or metronidazole [17]. Our patient's microorgan-
ism was later found to be susceptible in vitro to all the above
antibiotics. Erythromycin, commonly used in upper respira-
tory infections, is not active against Fusobacterium. In addition
to the prolonged antimicrobial therapy, appropriate drainage
of purulent collections is essential. Short-term anticoagula-
tion may be of value in the management of the disease but
controlled studies are lacking.
Compared to the preantibiotic era, serious infections invol-
ving F. necrophorum are unusual, making them potentially
more treacherous. Successful management requires timely
diagnosis and therapy.Without a high degree of clinical suspi-
cion, the diagnosis may be overlooked.
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